The Investor
07 May 2025, 09:50
IPG Photonics Q1 2025 Earnings Summary
IPG Photonics reported a weaker first quarter compared to the prior year but exceeded internal guidance on revenue, adjusted EPS, and adjusted EBITDA, supported by growth in medical, micromachining, and advanced applications.
Q1 2025 Key Figures (Year-over-Year Change):
• Revenue: $227.8 million (down 10%)
• Gross margin: 39.4% (up 70 basis points)
• Operating income: $1.8 million (down 91%)
• Operating margin: 0.8% (down from 7.6%)
• Net income: $3.8 million (down 84%)
• GAAP EPS: $0.09 (down from $0.52)
• Adjusted EPS: $0.31 (down 38%)
• Adjusted EBITDA: $32.7 million (down 19%)
Market and Product Highlights:
• Materials processing sales, representing 86% of total revenue, declined 14% due to reduced welding and cutting demand.
• Sales in other applications, including medical and advanced segments, rose 25%.
• Emerging growth products accounted for 51% of total revenue, compared to 48% in the prior quarter.
• Regional performance: sales rose 8% in Asia, declined 12% in North America, and dropped 28% in Europe.
Profitability and Cost Management:
• Adjusted gross margin increased to 40.0%, up from 38.9%.
• Adjusted operating income reached $7.7 million, down from $15.4 million.
• Adjusted tax rate was 21%, compared to 23% in Q1 2024.
Cash Flow and Liquidity:
• Cash from operations totaled $13.4 million, down from $54.6 million.
• Capital expenditures were $25 million.
• Total cash and short-term investments stood at $926.9 million with no debt reported.
Q2 2025 Outlook:
• Expected revenue: $210 million to $240 million
• Adjusted gross margin: 36% to 38% (including 150–200 basis point impact from tariffs)
• Operating expenses: $86 million to $88 million
• Adjusted EPS: between -$0.05 and $0.25
• Adjusted EBITDA: $16 million to $31 million
CEO Mark Gitin highlighted strong bookings, traction in new strategic areas, and the company’s flexibility in mitigating tariff-related shipment delays through its global manufacturing footprint.
IPG Photonics reported a weaker first quarter compared to the prior year but exceeded internal guidance on revenue, adjusted EPS, and adjusted EBITDA, supported by growth in medical, micromachining, and advanced applications.
Q1 2025 Key Figures (Year-over-Year Change):
• Revenue: $227.8 million (down 10%)
• Gross margin: 39.4% (up 70 basis points)
• Operating income: $1.8 million (down 91%)
• Operating margin: 0.8% (down from 7.6%)
• Net income: $3.8 million (down 84%)
• GAAP EPS: $0.09 (down from $0.52)
• Adjusted EPS: $0.31 (down 38%)
• Adjusted EBITDA: $32.7 million (down 19%)
Market and Product Highlights:
• Materials processing sales, representing 86% of total revenue, declined 14% due to reduced welding and cutting demand.
• Sales in other applications, including medical and advanced segments, rose 25%.
• Emerging growth products accounted for 51% of total revenue, compared to 48% in the prior quarter.
• Regional performance: sales rose 8% in Asia, declined 12% in North America, and dropped 28% in Europe.
Profitability and Cost Management:
• Adjusted gross margin increased to 40.0%, up from 38.9%.
• Adjusted operating income reached $7.7 million, down from $15.4 million.
• Adjusted tax rate was 21%, compared to 23% in Q1 2024.
Cash Flow and Liquidity:
• Cash from operations totaled $13.4 million, down from $54.6 million.
• Capital expenditures were $25 million.
• Total cash and short-term investments stood at $926.9 million with no debt reported.
Q2 2025 Outlook:
• Expected revenue: $210 million to $240 million
• Adjusted gross margin: 36% to 38% (including 150–200 basis point impact from tariffs)
• Operating expenses: $86 million to $88 million
• Adjusted EPS: between -$0.05 and $0.25
• Adjusted EBITDA: $16 million to $31 million
CEO Mark Gitin highlighted strong bookings, traction in new strategic areas, and the company’s flexibility in mitigating tariff-related shipment delays through its global manufacturing footprint.
